France · Source-listed medicine information

France / CIS 61056501

NIQUITIN 21 mg/24 heures, dispositif transdermique

dispositif · transdermique

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formdispositif
Routetransdermique
Ingredient entries1
CountryFrance

Product identity

At a glance

Authorisation holder
LABORATOIRE PERRIGO FRANCE
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 61056501

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for NIQUITIN 21 mg/24 heures, dispositif transdermique
IngredientStrength / referenceSource role
NICOTINEdispositif114 mgun dispositif transdermique de 22 cm^^2SAGroup 1

Pack references

Presentations (4)

7 dispositif(s) en sachet(s) polytéréphtalate (PET) polyéthylène aluminium EVOH : éthylène alcool vinylique

CIP13 3400930260418

Présentation active · Déclaration d'arrêt de commercialisation
28 dispositif(s) en sachet(s) polytéréphtalate (PET) polyéthylène aluminium EVOH : éthylène alcool vinylique

CIP13 3400930260432

Présentation active · Déclaration de commercialisation
7 dispositif(s) en sachet(s) polytéréphtalate (PET) polyéthylène aluminium copolymère d'acrilonitrile

CIP13 3400937955720

Présentation active · Déclaration d'arrêt de commercialisation
28 dispositif(s) en sachet(s) polytéréphtalate (PET) polyéthylène aluminium copolymère d'acrilonitrile

CIP13 3400937955959

Présentation active · Déclaration d'arrêt de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 61056501 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →